1st Annual Meeting

Oct, 07th, 2013

Welcome and introduction (Naldini)

Workpackage presentations and discussions
WP1 - Establishment of robust protocols for correction of the IL2RG gene in SCID-X1 (Naldini, Thrasher, Schmidt)

WP2 - Establishment of robust protocols for TCR gene edit. in T lymphocytes for the treatment of leukemias (Bonini, Naldini)
WP3 - Development and scale-up of manufacturing of HSPC and T-cell products
WP4 - Innovation, Exploitation, Dissemination
WP5 – Coordination, Management, Ethics

Implementation of the advisory boards: SAB, IPTTC
Questions related to the Intellectual Property and exploitation
Action plan for the next six months